Corentec Co., Ltd. announced that it expects to receive KRW 20 billion in funding
October 27, 2021
Share
Corentec Co., Ltd. announced a 9th unregistered nonguaranteed private placement convertible bond for gross proceeds of KRW 20,000,000,000 on October 28, 2021. The bonds will be converted into 1,376,083 shares. The transaction has been approved by the board of directors of the company
Corentec Co., Ltd. is a Korea-based company engaged in the development, manufacture and sale of orthopedic implants. The Companyâs products consist of hip products, including primary systems, hemi-arthroplasty systems and revision systems, such as cementless femoral stems, cemented femoral stems, cups for acetabular systems, bearing systems and others; knee products, including primary knee system fixed type, primary knee system mobile type, revision knee systems and augments systems, and spine products, including pedicle screws and peek cages. The Company mainly provides its hip products under the brand name of BENCOX, knee products under the brand name of LOSPA and spine products under the brand name of LOSPA IS. The Company distributes its products within domestic market and to overseas markets.
CORENTEC CO., LTD. 
